Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)
CNY 8.14
(-0.25%)
CNY 8.14
(-0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 845.34 Million | 1.03 Billion | 1.14 Billion | 833.8 Million | 1.02 Billion | 740.42 Million |
| Cost of Revenue | 109.35 Million | 84.06 Million | 80.95 Million | 62.83 Million | 73.34 Million | 76.29 Million |
| Gross Profit | 735.98 Million | 947.09 Million | 1.05 Billion | 770.96 Million | 955.95 Million | 664.12 Million |
| Operating Expenses | 679.56 Million | 823.55 Million | 870.9 Million | 606.61 Million | 705.31 Million | 530.87 Million |
| Selling, General and Administrative Expenses | 450.35 Million | 567.57 Million | 616.1 Million | 444.35 Million | 543.96 Million | 444.04 Million |
| Research and Development Expenses | 248.71 Million | 226.85 Million | 224.38 Million | 139.26 Million | 127.82 Million | 114.28 Million |
| Other Expenses | -19.49 Million | 29.12 Million | 30.41 Million | 22.98 Million | 33.52 Million | 1.6 Million |
| Cost and Expenses | 753.64 Million | 907.61 Million | 951.86 Million | 669.45 Million | 778.65 Million | 607.16 Million |
| Operating Income | 97.08 Million | 133.27 Million | 217.37 Million | 173.03 Million | 247.48 Million | 150.26 Million |
| Interest Expense | 3.18 Million | 1.53 Million | 1.05 Million | 5.6 Million | 6.29 Million | 6.49 Million |
| Income Tax Expense | -10.92 Million | -4.97 Million | 3.54 Million | 12.44 Million | 25.65 Million | 13.3 Million |
| Earnings before Tax | 97.52 Million | 132.29 Million | 215.92 Million | 176.7 Million | 246.31 Million | 143.07 Million |
| Net Income | 108.62 Million | 137.99 Million | 213.29 Million | 164.66 Million | 227.35 Million | 150.98 Million |
| Earnings Per Share Basic | 0.11 | 0.13 | 0.20 | 0.17 | 0.25 | 0.16 |
| Earnings Per Share Diluted | 0.11 | 0.13 | 0.20 | 0.17 | 0.25 | 0.16 |
| Weighted Average Shares Outstanding | 1.03 Billion | 1.03 Billion | 1.04 Billion | 989.41 Million | 923 Million | 923 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.03 Billion | 1.03 Billion | 1.04 Billion | 989.41 Million | 923 Million | 923 Million |
| Gross Margin | 0.87 | 0.92 | 0.93 | 0.92 | 0.93 | 0.90 |
| EBIT Margin | 0.22 | 0.19 | 0.22 | 0.27 | 0.31 | 0.27 |
| Profit Margin | 0.13 | 0.13 | 0.19 | 0.20 | 0.22 | 0.20 |
| EBITDA | 186.48 Million | 236.56 Million | 280.51 Million | 240.12 Million | 319.48 Million | 157.39 Million |
| Earnings Before Tax Margin | 0.11 | 0.13 | 0.19 | 0.21 | 0.24 | 0.20 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 138.22 Million | 258.94 Million | 146.37 Million | 845.34 Million | 141.27 Million | 185.13 Million |
| Cost of Revenue | 15.65 Million | 28.99 Million | 10.87 Million | 109.35 Million | 24.51 Million | 13.39 Million |
| Gross Profit | 122.57 Million | 229.94 Million | 135.5 Million | 735.98 Million | 116.76 Million | 171.74 Million |
| Operating Expenses | 117.97 Million | 178.94 Million | 139.97 Million | 659.12 Million | 119.56 Million | 146.72 Million |
| Selling, General and Administrative Expenses | 37.12 Million | 92.57 Million | 76.24 Million | - | 42.54 Million | 175.51 Million |
| Research and Development Expenses | 81.15 Million | 85.29 Million | 63.61 Million | - | 70.82 Million | 50.58 Million |
| Other Expenses | 303.97 Thousand | -1.06 Million | -116.02 Thousand | -3.46 Million | -6.19 Million | -554.26 Thousand |
| Cost and Expenses | 133.62 Million | 207.93 Million | 150.85 Million | 768.47 Million | 144.07 Million | 160.11 Million |
| Operating Income | 4.6 Million | 51 Million | -4.47 Million | 76.86 Million | -2.8 Million | 20.83 Million |
| Interest Expense | 155.42 Thousand | 108.48 Thousand | 162.31 Thousand | 3.06 Million | 381.82 Thousand | 862.43 Thousand |
| Income Tax Expense | -4.07 Million | 2.77 Million | -930.61 Thousand | -10.92 Million | -5.01 Million | -730.89 Thousand |
| Earnings before Tax | 11.21 Million | 74.87 Million | 4.8 Million | 121.06 Million | 24.77 Million | 20.47 Million |
| Net Income | 15.99 Million | 68.12 Million | 2.34 Million | 108.62 Million | 18.73 Million | 21.45 Million |
| Earnings Per Share Basic | 0.02 | 0.07 | 0.00 | - | 0.02 | 0.02 |
| Earnings Per Share Diluted | 0.02 | 0.07 | 0.00 | - | 0.02 | 0.02 |
| Weighted Average Shares Outstanding | 1.03 Billion | 1.03 Billion | 1.03 Billion | 1.03 Billion | 1.03 Billion | 1.03 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.03 Billion | 1.03 Billion | 1.03 Billion | 1.03 Billion | 1.03 Billion | 1.03 Billion |
| Gross Margin | 0.89 | 0.89 | 0.93 | 0.87 | 0.83 | 0.93 |
| EBIT Margin | 0.08 | 0.26 | 0.05 | - | 0.09 | 0.19 |
| Profit Margin | 0.12 | 0.26 | 0.02 | 0.13 | 0.13 | 0.12 |
| EBITDA | 11.36 Million | 68.11 Million | 7.03 Million | - | 12.01 Million | 34.94 Million |
| Earnings Before Tax Margin | 0.03 | 0.20 | -0.03 | 0.09 | -0.02 | 0.11 |
HYPOF
688315
HLFN
0LID
PETKM
GLL